Groupe la Francaise’s CareDx CDNA Stock Holding History

Groupe la Francaise’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-62	Closed	-$784	–	515
2025 Q3	$784	Buy	+62	New	+$884	﹤0.01%	742

Other funds holding CDNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Groupe la Francaise's CDNA Position: Q4 2025 in Review

Groupe la Francaise sold out of CareDx (CDNA) in Q4 2025, closing a stake of 62 shares — an estimated $784 sold.

Groupe la Francaise first reported a position in CDNA in Q3 2025 and held it in 1 quarter. The position peaked at $784 in Q3 2025. 200 funds tracked by Wall St. Rank hold CDNA as of Q4 2025.

Groupe la Francaise reported no remaining CareDx position as of Q4 2025 after selling out during the quarter.
Groupe la Francaise sold 62 CareDx shares in Q4 2025, an estimated $784.
Groupe la Francaise first reported a position in CareDx in Q3 2025 and held it in 1 quarter.
Groupe la Francaise's CareDx position peaked at $784 in Q3 2025.
200 funds tracked by Wall St. Rank held CareDx as of Q4 2025.

Based on Groupe la Francaise's 13F filing for Q4 2025, filed 12 Feb 2026.